Page 6 - நிறுவனம் பலகை ஆஃப் இயக்குநர்கள் தி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cedar Realty Trust Announces Appointment Of Three New Independent Directors

Cedar Realty Trust Announces Appointment Of Three New Independent Directors Reaches Agreements with Camac Partners and Ewing Morris & Co. News provided by Share this article Share this article PORT WASHINGTON, N.Y., April 28, 2021 /PRNewswire/ Cedar Realty Trust, Inc. (NYSE: CDR) ( Cedar or the Company ), today announced that it has agreed to appoint three new independent directors, Darcy D. Morris, Richard H. Ross, and Sharon Stern, to the Company s Board of Directors (the Board ), effective immediately, each with terms expiring at the Company s upcoming 2021 Annual Meeting of Shareholders (the 2021 Annual Meeting ). The Company has also agreed to nominate the three new independent directors for election at the 2021 Annual Meeting. In addition, longtime directors Pamela Hootkin and Roger Widmann will retire from the Board, effective as of the 2021 Annual Meeting. With the addition of the three new independent directors, the size of the Board will temporarily increase

United statesDarcyd morrisWilson sonsini goodrich rosatiRichardh rossPamela hootkinGregg gonsalvesEwing morrisRoger widmannMacdougall mactier incCamac partnersQueen universityUniversity of floridaGasthalter coMcgill university in economicsCedar realty trust incCompany annual report on form

Alfieri v Merrimack Pharmaceuticals: Employee Compensation

Friday, April 23, 2021 Preparing the terms of employee compensation can be a resource-intensive task requiring input from stakeholders across numerous departments, including human resources, finance, and legal. However, as the Massachusetts Appeals Court’s recent decision in Alfieri v. Merrimack Pharmaceuticals, Inc. demonstrates, investing those resources to complete the task will pay dividends when an employer is faced with a potentially costly claim for unpaid wages. Background In May 2014, Merrimack Pharmaceuticals, Inc. sent Michael Alfieri a letter offering him the position of corporate controller. In its offer letter, Merrimack explained that it would compensate Alfieri using a “total target cash compensation (‘TTCC’)” method under which it would pay him a percentage of his total compensation in biweekly salary payments and would retain a percentage to be paid in the first quarter of the following year. The offer letter set out three conditions that

United statesMichael alfieriAppeals courtCompany board of directors theMerrimack pharmaceuticals incMassachusetts appeals courtMerrimack pharmaceuticalsMassachusetts wage actWage actஒன்றுபட்டது மாநிலங்களில்மைக்கேல் ஆபிரிமுறையீடுகள் நீதிமன்றம்நிறுவனம் பலகை ஆஃப் இயக்குநர்கள் திமகிழ்ச்சி மருந்துகள் இன்க்மாசசூசெட்ஸ் முறையீடுகள் நீதிமன்றம்மகிழ்ச்சி மருந்துகள்

AST SPACEMOBILE, INC : Other Events (form 8-K)

AST SPACEMOBILE, INC : Other Events (form 8-K)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Exchange commissionDivision of corporationSpacemobile incProvidence acquisition corp the companyCompany board of directors thePurpose acquisition companies the staff statementEastern timeActing chief accountantActing directorCorporation financeStaff statementReporting considerationsWarrants issuedSpecial purpose acquisition companiesChief accountantProvidence acquisition corp

VIRTUS INVESTMENT PARTNERS, INC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)

Virtus Investment Partners, Inc. (the Company ) and Timothy A. Holt, Chairman of the Company s Board of Directors (the Board ), of his decision to retire as a member of the Board effective April 16, 2021 pursuant to the Board s retirement policy. Mr. Treanor s retirement is not the result of a disagreement with the Company. Mr. Treanor has served as a member of the Board since the Company became a public company in 2009 and as its Chairman from 2009 through February 2021. Compensation Committee and

Markc treanorTimothya holtGovernance committeeVirtus investment partners incCompensation committeeCompany board of directors theCertain officersCompensatory arrangementsInvestment partnersPage interactive data fileEdgar onlineVirtus investment partnersNc stock exchangePress releaseArk vrtsஆளுகை குழு

Prescience Point Capital Management to Nominate Four Highly Qualified Director Candidates to MiMedx Board at 2021 Annual Meeting

Prescience Point Capital Management to Nominate Four Highly Qualified Director Candidates to MiMedx Board at 2021 Annual Meeting Sends Letter to Fellow MiMedx Shareholders Citing Board s Failure to Maximize Shareholder Value News provided by Share this article Share this article BATON ROUGE, La., April 16, 2021 /PRNewswire/ Prescience Point Capital Management, together with its affiliates ( Prescience Point ), a research-focused, catalyst-driven investment firm, announced today the nomination of four highly qualified director candidates to the Board of Directors (the Board ) of MiMedx Group, Inc. (NASDAQ: MDXG) ( MiMedx or the Company ). Prescience Point, a beneficial owner of approximately 8.1% of the outstanding shares of MiMedx, believes that the best path forward for unlocking shareholder value is the addition of Mr. Eiad Asbahi, Mr. Alfred G. Merriweather, Ms. Charlotte E. Sibley, and Mr. William F. Spengler to the Board at the upcoming Annual Meeting of Shareholders

Eiad asbahiCharlottee sibleyWilliamf spenglerAlfredg merriweatherMimedx group incCompany board of directors thePrescience point capital managementMimedx groupPrescience pointAnnual meetingManaging partnerFellow mimedx shareholdersPoint capital managementGame changing product remains hiddenResulting in chronicநிறுவனம் பலகை ஆஃப் இயக்குநர்கள் தி